JUser: :_load: Unable to load user with ID: 38242

Over-treatment of Renal Tumors: The Turtle in the Room - Robert G. Uzzo

August 9, 2017

(Length of discussion - 11 minutes)

Kidney cancer, like all cancers, has a spectrum of risk. There are groups of patients with incidentally detected asymptomatic, small renal masses that act relatively indolent and are often over-diagnosed and over-treated in some patients. The issue is defining who they are when they should or should not be treated.

Related Content:

Watch: Adjuvant Therapies for Renal Cell Carcinoma - Robert Uzzo

Perioperative Systemic Therapy for Kidney Cancer: Current Data and Ongoing Trials

Best of Journals: Renal Cell Carcinoma – Urologic Oncology - Session Highlights


Robert G. Uzzo, MD 

Chair, Department of Surgical Oncology

G. Willing "Wing" Pepper Chair in Cancer Research

Kidney, Bladder, and Prostate Cancer TRDG Member

Senior Vice-President, Physician Services

President, FCCC Medical Group, Inc.

Professor of Surgery, Temple University Health System

E. David Crawford